Skip to main navigation Skip to search Skip to main content

Human B cell development and antibody production in humanized NOD/SCID/IL-2Rγnull (NSG) mice conditioned by busulfan

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Busulfan treatment as a chemotherapeutic agent has been considered an alternative approach in xenograft model because it offers a simple, convenient, effective, and less toxic conditioning regimen. Objective and methods: To investigate busulfan effects on the reconstitution of human immune cells and the generation of immune response to foreign antigens, we generated humanized NOD/SCID/IL-2Rγnull (NSG) mice conditioned either busulfan or total body irradiation (TBI) with hCD34+ CB cells. Results: Busulfan resulted in a high survival rate and effective reconstitution of human immune cells including B, T, macrophage, and dendritic cells in humanized NSG mice, compared to that of TBI. Moreover, the humanized NSG mice conditioned busulfan showed effective B cell development and thereby the high production of human antibody against immunized antigen. Conclusion: Humanized mice conditioned by busulfan provide a powerful and versatile tool for studying the entire process of human B-lymphocyte development and for producing specific human antibodies.

Original languageEnglish
Pages (from-to)253-264
Number of pages12
JournalJournal of Clinical Immunology
Volume31
Issue number2
DOIs
StatePublished - Apr 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Busulfan
  • CD34 cord blood cells
  • humanized mice
  • NOD/SCID/IL-2Rγ mouse
  • xenograft model

Fingerprint

Dive into the research topics of 'Human B cell development and antibody production in humanized NOD/SCID/IL-2Rγnull (NSG) mice conditioned by busulfan'. Together they form a unique fingerprint.

Cite this